Bioconjugate Process Development Lead

CH12 Lonza AG; Oberwallis; On-site; CHF 120,000 - 170,000; Full time

Benefits offered by this job

Agile culture

Inclusive workplace

Performance-based pay

Role/location benefits

Job summary

Lonza Group Ltd. in Visp, Switzerland, is expanding its Bioconjugates process development team. We seek a PhD scientist with an interest in bioconjugates to lead external customer projects and transfer processes into GMP facilities.

The role emphasizes hands-on experimentation, collaboration across multidisciplinary teams, and serving as primary on-site interface for customers, driving innovation and high-quality biologics through scalable manufacturing.

Qualifications

• PhD in life sciences, ideally multidisciplinary for bioconjugation.
• Process development experience with bioconjugates.
• Excellent communication and relationship-building skills.
• Strong team player with structured, solution-oriented mindset.
• Fluent in English; German is a plus.

Responsibilities

• Develop scalable processes for antibody drug conjugates and other bioconjugates for external customers.
• Plan, supervise and evaluate laboratory experiments with the lab team.
• Present results internally and externally.
• Collaborate in Lonza’s cross-functional project teams and with external customers.
• Lead process development projects for preclinical programs as the primary on-site interface for customers.
• Anticipate and implement trends and innovations in the area of expertise.

Skills

Fluent English

German language knowledge

Excellent communication skills

Strong teamwork

Structured, organized work style

Agile, proactive

Education

PhD in life sciences

Job description

Lonza Group Ltd. in Visp, Switzerland, is expanding its Bioconjugates process development team. We seek a PhD scientist with an interest in bioconjugates to lead external customer projects and transfer processes into GMP facilities.

The role emphasizes hands-on experimentation, collaboration across multidisciplinary teams, and serving as primary on-site interface for customers, driving innovation and high-quality biologics through scalable manufacturing.